STOCK TITAN

InterCure (INCR) sets voting process for August 11 extraordinary shareholder meeting

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

InterCure Ltd. outlines voting procedures for its Extraordinary General Meeting of Shareholders scheduled for August 11, 2026 at 4:00 p.m. (Israel time) in Tel Aviv. The company clarifies that it has not engaged Broadridge or similar providers, so shareholders must follow procedures under the Israeli Companies Law.

Shareholders of record as of July 29, 2026 may vote by attending in person or by submitting a proxy card to the company by 11:59 p.m. Eastern Time on August 10, 2026. Holders through banks or brokers can vote in person with a legal proxy, by mailing or emailing a proxy plus legal proxy, or via the Israel Securities Authority’s electronic voting system on the MAGNA platform up to six hours before the meeting. Proxy materials and forms are available on the ISA, TASE and SEC websites and directly from the company.

Positive

  • None.

Negative

  • None.
Meeting date and time August 11, 2026 at 4:00 p.m. (Israel time) Scheduled time of the Extraordinary General Meeting of Shareholders
Record Date July 29, 2026 Date at close of business determining shareholders entitled to vote
Proxy receipt deadline 11:59 p.m. Eastern Time on August 10, 2026 Deadline for the company to receive mailed or emailed proxy cards
Electronic voting cutoff Six (6) hours before the time of the Meeting Latest time to vote via the Israel Securities Authority MAGNA system
Extraordinary General Meeting of Shareholders regulatory
"the Company will hold an Extraordinary General Meeting of Shareholders"
A meeting called by a company outside its regular annual meeting to address urgent or special matters that cannot wait until the next scheduled meeting. Investors attend or vote to decide on actions such as major deals, leadership changes, capital-raising, or rule changes; think of it as an emergency board meeting where shareholders have a direct say and the outcomes can quickly change a company’s strategy, ownership stakes, or financial prospects.
Israeli Companies Law, 5759-1999 regulatory
"in accordance with the Israeli Companies Law, 5759-1999"
Israel Securities Authority’s Electronic Voting System regulatory
"may vote their shares through such electronic voting system"
MAGNA online platform regulatory
"has established an electronic voting system via its MAGNA online platform"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

When and where is InterCure (INCR) holding its Extraordinary General Meeting?

InterCure will hold its Extraordinary General Meeting on August 11, 2026 at 4:00 p.m. (Israel time) at its attorneys’ offices in Ramat Hachayal, Tel Aviv. The meeting will address proposals described in previously furnished proxy materials.

What is the record date for voting at InterCure (INCR)'s August 2026 meeting?

The record date for voting rights is July 29, 2026. Only shareholders of record at the close of business on that date are entitled to receive notice of, and vote at, the Extraordinary General Meeting and any adjournment or postponement.

How can registered InterCure (INCR) shareholders vote their shares?

Shareholders registered directly in InterCure’s Israeli share register may vote by attending in person or by sending a completed, dated and signed proxy card by mail or email so it is received by 11:59 p.m. Eastern Time on August 10, 2026.

How do InterCure (INCR) shareholders holding in street name vote at the meeting?

Street-name holders must first obtain a legal proxy from their bank, broker or nominee. They may then vote in person with that proxy, send it with a proxy card by mail or email, or vote via the Israel Securities Authority’s electronic voting system up to six hours before the meeting.

Does InterCure (INCR) use Broadridge for this Extraordinary General Meeting?

InterCure has not engaged Broadridge Financial Solutions, Inc. or any similar service provider to distribute proxy materials or tabulate votes. Shareholders must follow the voting procedures described under the Israeli Companies Law and related regulations instead.

Where can InterCure (INCR) shareholders access the proxy materials and proxy card?

The proxy materials and proxy card are available on the Israel Securities Authority’s MAGNA website, the Tel Aviv Stock Exchange website, and the SEC website. Shareholders may also request a copy of the proxy card directly from InterCure using the provided contact details.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of August 2026

 

Commission File Number: 001-40614

 

INTERCURE LTD.

(Translation of registrant’s name into English)

 

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

As previously reported, the Company will hold an Extraordinary General Meeting of Shareholders (the “Meeting”) on August 11, 2026 at 4:00 p.m. (Israel time), at the offices of the Company’s attorneys, Amit, Pollak, Matalon, at APM House, 18 Raoul Wallenberg St., Building D, 6th floor, Ramat Hachayal, Tel Aviv, Israel. The Meeting was originally announced in the Company’s Report on Form 6-K filed with the Securities and Exchange Commission (the “SEC”) on July 22, 2026. The date of the Meeting was subsequently corrected from August 12, 2026 to August 11, 2026 pursuant to the Company’s Amendment No. 1 on Form 6-K/A filed with the Securities and Exchange Commission on July 27, 2026. The amended Notice and Proxy Statement and proxy card were previously filed to the SEC on July 27, 2026.

 

IMPORTANT NOTICE REGARDING VOTING PROCEDURES

 

The Company has not engaged Broadridge Financial Solutions, Inc. or any similar service provider to distribute proxy materials or tabulate votes for the Meeting. Accordingly, shareholders who wish to vote at the Meeting are requested to follow the procedures set forth below, in accordance with the Israeli Companies Law, 5759-1999 (the “Israeli Companies Law”) and the regulations promulgated thereunder.

 

A form of proxy card for the Meeting is available to the public on the distribution website of the Israel Securities Authority at http://www.magna.isa.gov.il and on the website of the Tel Aviv Stock Exchange at http://www.tase.co.il. The proxy card has also been furnished to the SEC as an exhibit to a Report of Foreign Private Issuer on Form 6-K and is available on the SEC’s website at http://www.sec.gov. Shareholders may also request a copy of the proxy card directly from the Company using the contact information set forth below.

 

Shareholders Registered in the Company’s Shareholders Register

 

Shareholders whose shares are registered directly in the Company’s shareholders register in Israel may vote their shares (i) by attending the Meeting in person; or (ii) by completing, dating, signing and mailing a proxy card to the Company’s offices at 85 Medinat ha-Yehudim Street, Herzliya 4676670, Israel, Attention: Chief Financial Officer, or by email to amos@intercure.co, so that it is received no later than 11:59 p.m., Eastern Time,  on August 10, 2026.

 

Shareholders Holding Shares Through a Bank, Broker or Other Nominee

 

Shareholders who hold ordinary shares through a bank, broker or other nominee (i.e., in “street name”) may vote their shares by one of the following methods:

 

(a)By attending the Meeting in person: Such shareholders must obtain a legal proxy from their bank, broker or nominee evidencing ownership as of the record date, and present such legal proxy together with valid identification at the Meeting.
(b)By proxy: Such shareholders must obtain a legal proxy from their bank, broker or nominee evidencing ownership as of the record date. The legal proxy, together with the completed, dated and signed proxy card, should be mailed to the Company’s offices at 85 Medinat ha-Yehudim Street, Herzliya 4676670, Israel, Attention: Chief Financial Officer, or sent by email to amos@intercure.co, so that it is received no later than 11:59 p.m., Eastern Time,  on August 10, 2026.
(c)Via the Israel Securities Authority’s Electronic Voting System: In accordance with the Israeli Companies Law and regulations promulgated thereunder, the Israel Securities Authority has established an electronic voting system via its MAGNA online platform. Shareholders holding shares through members of the Tel Aviv Stock Exchange may vote their shares through such electronic voting system, following a registration process, no later than six (6) hours before the time of the Meeting. Shareholders wishing to use this voting method should contact their broker for instructions.

 

Record Date

 

Only shareholders of record at the close of business on July 29, 2026 (the “Record Date”) are entitled to notice of, and to vote at, the Meeting and any adjournment or postponement thereof.

 

In connection with the Meeting, the Company previously furnished the following documents to the SEC:

 

  1. The amended Notice and Proxy Statement with respect to the Meeting, describing the proposal to be voted upon, the procedures for voting in person or by proxy, and other information relating to the Meeting, as filed as Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on July 27, 2026; and
     
  2. The form of proxy card for holders of the Company’s ordinary shares, as filed as Exhibit 99.2 to the Company’s Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on July 27, 2026.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INTERCURE LTD.
   
Date: August 4, 2026 /s/ Amos Cohen
  Amos Cohen
  Chief Financial Officer